Cargando…
A simple and automated method for (161)Tb purification and ICP-MS analysis of (161)Tb
BACKGROUND: (161)Tb is a radiolanthanide with the potential to replace (177)Lu in targeted radionuclide therapy. (161)Tb is produced via the neutron irradiation of [(160)Gd]Gd(2)O(3) targets, and must be purified from (160)Gd and the decay product (161)Dy prior to use. Established purification metho...
Autores principales: | McNeil, Scott W., Van de Voorde, Michiel, Zhang, Chengcheng, Ooms, Maarten, Bénard, François, Radchenko, Valery, Yang, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718904/ https://www.ncbi.nlm.nih.gov/pubmed/36459299 http://dx.doi.org/10.1186/s41181-022-00183-y |
Ejemplares similares
-
Preclinical Evaluation of [(155/161)Tb]Tb-Crown-TATE—A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours
por: Wharton, Luke, et al.
Publicado: (2023) -
(161)Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of (161)Tb into the Clinic
por: Favaretto, Chiara, et al.
Publicado: (2023) -
Establishment of a clinical SPECT/CT protocol for imaging of (161)Tb
por: Marin, I., et al.
Publicado: (2020) -
Radiation doses from (161)Tb and (177)Lu in single tumour cells and micrometastases
por: Alcocer-Ávila, Mario E., et al.
Publicado: (2020) -
Radiolabeling of Human Serum Albumin With Terbium-161 Using Mild Conditions and Evaluation of in vivo Stability
por: Cassells, Irwin, et al.
Publicado: (2021)